Navigation Links
Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS)

LONDON, Sept. 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) has completed a preliminary review of the HTDS business model. ECM is providing an informative report to all HTDS followers at the following link

Equity Capital Management PLC, (ECM) believes that in the current economic climate there are distinct opportunities to purchase under-performing asset-rich businesses ECM business model is to target such under performing companies. ECM believes HTDS is a good target for the acquisition because it is an under-performing and undervalued company, with a great potential. ECM has not been paid in cash or stock for this report on HTDS. ECM may invoice the company for a voluntary cash payment should its report prove to be of assistance to the company.

The entire report will be posted on ECM web site:

The report may also be available on under the "FILING TAB" with the sub heading "Management Discussion and Analysis" or this direct link


ECM is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Please read our report for complete risks and disclosures.


SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimers Immunotherapy Program and Equity Investment
2. Abaxis, Inc. to Present at the ThinkEquity Sixth Annual Growth Conference
3. Omnicell to Present at Think Equitys 6th Annual Growth Conference
4. Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders Equity
5. MassMutual Analysis: Whole Life Insurance Can Help Supply Retirement Income, Preserve Equity Portfolios During Bear Markets
6. Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured
7. Smart Ideas at the Intersection of Transportation, Health, and Equity
8. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
9. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimers Immunotherapy Program and Equity Investment
10. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
11. Lumenis Completes $15 Million Equity Financing From New and Existing Investors
Post Your Comments:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Safe storage ... creativity of two inventors, one from Lakewood, New Jersey and the other from Bradley ... the patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often ...
(Date:11/28/2015)... ... ... a.m. EST until 11:59 p.m. EST, customers will be racing the clock ... $80 or more to free gifts with purchases, there will be a new sale available ... for skin care and cosmetic needs, customers will save on already discounted prices. , Top ...
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the ... has not been an easy question to answer. Especially when the senior partners and ... don’t share the same discipline around working long hours. , In addition to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: